KORU Medical Systems Inc. has amended and restated its bylaws, introducing enhanced procedural and disclosure requirements for stockholder nominations of directors and proposals at annual and special meetings. The changes require additional disclosures and acknowledgments from nominating stockholders and related parties, and adjust the advance notice deadline for director nominations in certain situations, in line with updated SEC rules on universal proxy cards.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. KORU Medical Systems Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001161697-26-000038), on February 11, 2026, and is solely responsible for the information contained therein.